Zimmer Biomet Holdings ROE 2010-2024 | ZBH
Current and historical return on equity (ROE) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Zimmer Biomet Holdings ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $0.90B | $12.48B | 7.20% |
| 2024-09-30 | $1.08B | $12.38B | 8.63% |
| 2024-06-30 | $1.00B | $12.75B | 7.92% |
| 2024-03-31 | $0.96B | $12.61B | 7.71% |
| 2023-12-31 | $1.03B | $12.49B | 8.28% |
| 2023-09-30 | $0.48B | $12.52B | 3.88% |
| 2023-06-30 | $0.51B | $12.38B | 4.15% |
| 2023-03-31 | $0.45B | $12.16B | 3.71% |
| 2022-12-31 | $0.23B | $12.03B | 1.92% |
| 2022-09-30 | $0.28B | $12.25B | 2.26% |
| 2022-06-30 | $0.23B | $12.13B | 1.85% |
| 2022-03-31 | $0.22B | $12.02B | 1.74% |
| 2021-12-31 | $0.40B | $12.67B | 3.19% |
| 2021-09-30 | $0.82B | $12.71B | 6.58% |
| 2021-06-30 | $0.92B | $12.58B | 7.48% |
| 2021-03-31 | $0.57B | $12.45B | 4.72% |
| 2020-12-31 | $-0.14B | $12.20B | -1.17% |
| 2020-09-30 | $-0.15B | $11.88B | -1.27% |
| 2020-06-30 | $0.04B | $11.64B | 0.30% |
| 2020-03-31 | $0.38B | $11.88B | 3.14% |
| 2019-12-31 | $1.13B | $12.39B | 9.50% |
| 2019-09-30 | $-0.09B | $12.09B | -0.77% |
| 2019-06-30 | $-0.36B | $11.66B | -3.07% |
| 2019-03-31 | $-0.31B | $11.54B | -2.62% |
| 2018-12-31 | $-0.38B | $11.28B | -3.19% |
| 2018-09-30 | $1.75B | $12.22B | 14.61% |
| 2018-06-30 | $1.69B | $12.04B | 14.62% |
| 2018-03-31 | $1.69B | $12.00B | 15.19% |
| 2017-12-31 | $1.81B | $11.74B | 17.10% |
| 2017-09-30 | $0.65B | $10.45B | 6.47% |
| 2017-06-30 | $0.71B | $10.28B | 7.19% |
| 2017-03-31 | $0.50B | $9.93B | 5.11% |
| 2016-12-31 | $0.31B | $9.67B | 3.18% |
| 2016-09-30 | $0.36B | $9.75B | 3.75% |
| 2016-06-30 | $0.23B | $9.55B | 2.32% |
| 2016-03-31 | $0.08B | $9.66B | 0.85% |
| 2015-12-31 | $0.15B | $9.89B | 1.60% |
| 2015-09-30 | $0.17B | $9.99B | 2.02% |
| 2015-06-30 | $0.32B | $10.13B | 4.28% |
| 2015-03-31 | $0.67B | $6.58B | 10.26% |
| 2014-12-31 | $0.72B | $6.55B | 11.19% |
| 2014-09-30 | $0.83B | $6.54B | 12.96% |
| 2014-06-30 | $0.81B | $6.45B | 12.86% |
| 2014-03-31 | $0.78B | $6.24B | 12.75% |
| 2013-12-31 | $0.78B | $6.30B | 12.98% |
| 2013-09-30 | $0.68B | $6.14B | 11.49% |
| 2013-06-30 | $0.70B | $5.89B | 12.05% |
| 2013-03-31 | $0.77B | $5.71B | 13.23% |
| 2012-12-31 | $0.76B | $5.87B | 13.11% |
| 2012-09-30 | $0.76B | $5.83B | 13.38% |
| 2012-06-30 | $0.77B | $5.71B | 13.76% |
| 2012-03-31 | $0.76B | $5.66B | 13.38% |
| 2011-12-31 | $0.76B | $5.52B | 13.25% |
| 2011-09-30 | $0.64B | $5.61B | 11.01% |
| 2011-06-30 | $0.64B | $6.02B | 10.89% |
| 2011-03-31 | $0.60B | $5.86B | 10.37% |
| 2010-12-31 | $0.60B | $5.77B | 10.36% |
| 2010-09-30 | $0.72B | $5.82B | 12.52% |
| 2010-06-30 | $0.68B | $5.74B | 11.72% |
| 2010-03-31 | $0.72B | $5.71B | 12.45% |
| 2009-12-31 | $0.72B | $5.64B | 12.48% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $19.288B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.526B | 27.00 |
| Boston Scientific (BSX) | United States | $152.309B | 38.13 |
| Stryker (SYK) | United States | $147.916B | 30.93 |
| EssilorLuxottica (ESLOY) | France | $129.703B | 0.00 |
| Medtronic (MDT) | Ireland | $109.157B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.583B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.109B | 26.80 |
| ResMed (RMD) | United States | $36.312B | 27.27 |
| GE HealthCare Technologies (GEHC) | United States | $33.806B | 16.05 |
| Agilent Technologies (A) | United States | $32.907B | 21.74 |
| Terumo (TRUMY) | Japan | $27.953B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.765B | 16.36 |
| Insulet (PODD) | United States | $22.130B | 86.87 |
| Baxter (BAX) | United States | $15.985B | 11.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.381B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.091B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.462B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.298B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.605B | 9.14 |
| ICU Medical (ICUI) | United States | $3.534B | 26.06 |
| Haemonetics (HAE) | United States | $3.473B | 15.13 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| QuidelOrtho (QDEL) | United States | $2.401B | 16.52 |
| GN Store Nord (GNNDY) | Denmark | $2.164B | 17.92 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.06 |
| AtriCure (ATRC) | United States | $1.558B | 0.00 |
| Neogen (NEOG) | United States | $1.409B | 18.03 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.179B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.172B | 26.35 |
| BioLife Solutions (BLFS) | United States | $1.097B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 9.50 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.75 |
| Evolus (EOLS) | United States | $0.653B | 0.00 |
| CeriBell (CBLL) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.559B | 4.63 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Surmodics (SRDX) | United States | $0.398B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.350B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.312B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.309B | 11.36 |
| Aurora Cannabis (ACB) | Canada | $0.290B | 51.60 |
| Sanuwave Health (SNWV) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.97 |
| Canopy Growth (CGC) | Canada | $0.267B | 0.00 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.255B | 0.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 11.28 |
| Biote (BTMD) | United States | $0.214B | 6.02 |
| OraSure Technologies (OSUR) | United States | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Brainsway (BWAY) | Israel | $0.185B | 49.05 |
| Quanterix (QTRX) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.47 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.19 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Exagen (XGN) | United States | $0.120B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.101B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.077B | 10.71 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Safety Shot (SHOT) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.020B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |